GlassScriptPhysician profile
Brett W Baker
NPI 1790882215
$4,143.89
in general payments reported to CMS, 2019-2025
36 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,769 · 2020: $267 · 2021: $308 · 2022: $433 · 2023: $336 · 2024: $522 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,366.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $986.09 | 2019 | |
| Abbvie INC. | $657.16 | 2019-2025 | Botox, Lupron Depot |
| Pfizer INC. | $416.33 | 2019-2025 | |
| Astellas Pharma US INC | $335.98 | 2019-2024 | Veozah |
| Teleflex LLC | $206.43 | 2022-2025 | Urolift |
| Innovation Technologies INC | $126.58 | 2024-2025 | Irrisept |
| Allergan, INC. | $124.00 | 2019-2021 | |
| Janssen Biotech, INC. | $103.13 | 2019-2025 | Erleada |
| Urogen Pharma, INC. | $89.73 | 2024-2025 | |
| Olympus America INC. | $85.52 | 2023-2024 | Itind System |
| Axonics, INC. | $80.89 | 2021-2023 | Axonics |
| Convatec INC. | $80.54 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $79.50 | 2019-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $72.88 | 2019-2024 | Provenge |
| Rochester Medical Corporation | $63.68 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $58.37 | 2023-2024 | Orgovyx, Gemtesa |
| Myovant Sciences INC. | $56.97 | 2021-2022 | |
| Inspire Medical Systems, INC. | $56.27 | 2025 | Inspire |
| Boston Scientific Corporation | $54.31 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $45.53 | 2022-2024 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $41.17 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $39.58 | 2019-2022 | |
| Foundation Medicine, INC. | $38.48 | 2023 | |
| Neotract INC. | $27.38 | 2019-2020 | |
| Medtronic USA, INC. | $24.40 | 2019 | |
| Alexion Pharmaceuticals, INC. | $23.25 | 2021 | |
| Merz North America, INC. | $21.40 | 2024 | |
| Myriad Genetic Laboratories, INC. | $20.43 | 2024 | Prolaris |
| Avadel Specialty Pharmaceuticals, LLC | $19.02 | 2019 | |
| Mission Pharmacal Company | $17.97 | 2019 | |
| Endo USA, INC. | $17.63 | 2025 | Aveed, Xiaflex |
| Procept Biorobotics Corporation | $16.23 | 2020 | |
| Travere Therapeutics, INC. | $15.30 | 2019 | |
| Acerus Pharmaceuticals Corporation | $14.75 | 2020 | |
| Coloplast Corp | $14.40 | 2021 | |
| Antares Pharma, INC. | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.